Can citalopram (Celexa) 10mg be stopped and mirtazapine (Remeron) 7.5mg be started without problems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Citalopram 10mg to Mirtazapine 7.5mg

You should NOT abruptly stop citalopram 10mg and immediately start mirtazapine 7.5mg—instead, implement a gradual cross-taper over 4-6 weeks to minimize withdrawal symptoms and serotonin syndrome risk. 1, 2

Why Abrupt Switching is Problematic

Citalopram Withdrawal Risk

  • Abrupt discontinuation of citalopram can cause severe withdrawal symptoms including dizziness, nausea, myalgias, anxiety, irritability, and even sustained hypertension requiring medical intervention 3
  • Discontinuing any antidepressant over 10-14 days is insufficient for patients on established therapy—this older recommendation does not adequately prevent withdrawal effects 1, 2
  • Even at the low dose of 10mg, gradual tapering is essential to avoid discontinuation symptoms 1

Serotonin Syndrome Concern

  • The primary safety concern when combining SSRIs with other serotonergic agents is serotonin syndrome, with symptoms typically arising within 24-48 hours of combining medications 2
  • While mirtazapine has a different mechanism (alpha-2 antagonist enhancing noradrenergic and 5-HT1 serotonergic transmission), it still affects serotonergic pathways 4, 5
  • Symptoms include mental status changes, neuromuscular hyperactivity (tremors, muscle twitching), autonomic hyperactivity (fever, sweating, rapid heart rate, diarrhea), and can be fatal if untreated 2

Recommended Cross-Taper Protocol

Week 1-2: Initiation Phase

  • Start mirtazapine 7.5mg at bedtime while maintaining citalopram 10mg 1, 2
  • Monitor intensively for serotonin syndrome symptoms in the first 24-48 hours (confusion, agitation, tremors, fever, sweating, rapid heart rate, diarrhea, muscle twitching) 2
  • Maintain this combination for 7-14 days to assess tolerability 2

Week 3-4: Begin Citalopram Taper

  • Reduce citalopram to 5mg daily after confirming mirtazapine tolerability 1, 2
  • Continue mirtazapine 7.5mg unchanged 1
  • Monitor for withdrawal symptoms (dizziness, nausea, anxiety, irritability) 3

Week 5-6: Complete Transition

  • Discontinue citalopram completely after 1-2 weeks at 5mg 1, 2
  • Continue mirtazapine 7.5mg at bedtime 1
  • If therapeutic effect is insufficient after citalopram is fully discontinued, mirtazapine can be increased to 15mg or 30mg as needed 1, 4

Monitoring Requirements

During Cross-Taper (Weeks 1-6)

  • Weekly contact (phone or in-person) is essential during the first month 2
  • Instruct patient to immediately report any signs of serotonin syndrome 2
  • Monitor blood pressure, as citalopram withdrawal can cause sustained hypertension 3

After Transition Complete

  • Monthly follow-up until stable on mirtazapine monotherapy 2
  • Note that mirtazapine's antidepressant effect may take 4-8 weeks for full therapeutic benefit 1

Critical Pitfalls to Avoid

  • DO NOT abruptly stop citalopram—even at 10mg, withdrawal symptoms can be severe and include sustained hypertension 3
  • DO NOT assume the low dose (10mg) makes tapering unnecessary—all SSRIs require gradual discontinuation 1, 2
  • DO NOT rapidly increase mirtazapine while citalopram remains in the system—wait until citalopram is at ≤5mg or discontinued before titrating mirtazapine upward 2
  • DO NOT abruptly stop mirtazapine if later discontinuation is needed—even after medium-term therapy (10 weeks), progressive tapering is advisable to avoid panic attacks and withdrawal symptoms 6

Special Considerations for Mirtazapine

Cardiovascular Safety

  • Mirtazapine has been shown to be safe in patients with cardiovascular disease, with no significant cardiovascular adverse effects even at high doses 1
  • Unlike citalopram/escitalopram, mirtazapine has lower risk of QTc prolongation 1

Additional Benefits

  • Mirtazapine offers appetite stimulation and sleep improvement, which may be advantageous if these are treatment goals 1
  • The 7.5mg dose is appropriate for initiating therapy, particularly for sleep benefits 1
  • Sedation is most prominent at lower doses and may decrease as dose increases 7

Timeline Summary

  • Total transition period: 4-6 weeks minimum 1, 2
  • This gradual approach prioritizes patient safety and minimizes risk of withdrawal symptoms, serotonin syndrome, and treatment discontinuation 1, 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.